Link Roundup, Week of November 9

On a semi-regular basis, we’ll share the latest news stories that have us excited/angry/optimistic…or at the very least, thinking and talking.

• 1.1 billion—that’s how many women are estimated to be postmenopausal by 2025. For most women, menopause presents an interference in their lives, and many suffer from severe physical and psychological symptoms. Yet investment in menopause still accounts for just 5% of femtech investment. (Female Founders Fund)

• The COVID-19 pandemic is disproportionately impacting Black Americans, a reflection of the many social, economic, and other inequities in our country. Mental health is no exception. What are the opportunities to intervene, including through better communication? (Psychiatric Times)

• More than 3 million people are estimated to have taken the memory supplement Prevagen. But from its launch in 2007 to 2016, serious complaints about adverse effects were filed, prompting alarm within the FDA. This wild tale underlines the gap in public perceptions about how the dietary supplements industry is regulated. (Wired)

• Amazon’s telemedicine service for their employees and dependents in Washington state has been hiring, prompting some to ask if an expansion beyond the company’s workforce is in store. What could the “Amazon effect” mean for the healthcare industry? (CNBC)

• Acadia Pharmaceutical’s unforgettable new marketing venture: Spark — Robin Williams and His Battle with Lewy Body Dementia, a new film exploring what’s still something of a medical mystery. (Fierce Pharma)